If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Patient Focused Services » Patient Advocacy Groups
Download FREE Excerpt
22 Info Graphics
8 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
Patient advocacy groups play a vital role in educating patients on new therapies and treatment options. Given their close relationship to patients, advocacy groups are critical partners for pharma as they seek to educate the public about new and existing therapies. The pharma function that works with patient advocacy groups has evolved as the industry seeks new and more effective ways to communicate with patient groups.
This research provides current benchmarks on the structure, staffing level, and communication processes that pharma advocacy groups are utilizing to increase their effectiveness. The study also contains a chapter that contains qualitative data from respondents regarding advocacy structure. Leaders who oversee the advocacy function within pharma can use this study to compare their metrics and structural approaches with their industry peers.
This study engaged 74 leaders supporting patient advocacy at 61 life sciences companies and organizations. More than 60% of participants are at the director/ senior director level. Nearly 65% of participants are from the United States.
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.